MetaCap

Evogene (EVGN) vs Lexaria Bioscience (LEXX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Lexaria Bioscience is the larger company by market cap ($6.7 million vs $6.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EVGN-2.95%LEXX-7.51%
+0%-4%-8%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EVGN versus LEXX key metrics
MetricEVGNLEXX
Share price$0.3985$3.20
Market cap$6.30M$6.74M
1-day change-2.95%-8.57%
EPS (TTM)$-1.55$-5.10
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.49$21.60
52-week low$0.35$2.77
Distance from 52-week high-73.26%-85.19%
Analyst consensusstrong_buynone
Avg. price target upside+439.52%+2478.12%
Average volume2.02M62.36K
Shares outstanding15.80M2.11M
Employees387
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Evogene

EVGN stock →

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications.

Healthcare · Biotechnology · 38 employees

About Lexaria Bioscience

LEXX stock →

Lexaria Bioscience Corp. operates as a biotechnology company.

Healthcare · Biotechnology · 7 employees

EVGN vs LEXX FAQ

Which is bigger, Evogene or Lexaria Bioscience?

Lexaria Bioscience (LEXX) is larger, with a market capitalization of $6.74M compared with $6.30M for Evogene (EVGN).

Are Evogene and Lexaria Bioscience in the same industry?

Yes. Both are classified in the Biotechnology industry within the Healthcare sector.

More comparisons